Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anika Therapeutics (ANIK) Non-Current Deffered Revenue (2016)

Historic Non-Current Deffered Revenue for Anika Therapeutics (ANIK) over the last 7 years, with Q4 2016 value amounting to $48000.0.

  • Anika Therapeutics' Non-Current Deffered Revenue fell 2727.27% to $48000.0 in Q4 2016 from the same period last year, while for Dec 2016 it was $48000.0, marking a year-over-year decrease of 2727.27%. This contributed to the annual value of $48000.0 for FY2016, which is 2727.27% down from last year.
  • As of Q4 2016, Anika Therapeutics' Non-Current Deffered Revenue stood at $48000.0, which was down 2727.27% from $59000.0 recorded in Q3 2016.
  • In the past 5 years, Anika Therapeutics' Non-Current Deffered Revenue registered a high of $4.3 million during Q1 2012, and its lowest value of $48000.0 during Q4 2016.
  • Its 5-year average for Non-Current Deffered Revenue is $1.1 million, with a median of $79940.5 in 2015.
  • As far as peak fluctuations go, Anika Therapeutics' Non-Current Deffered Revenue plummeted by 9721.01% in 2014, and later skyrocketed by 3074.08% in 2015.
  • Quarter analysis of 5 years shows Anika Therapeutics' Non-Current Deffered Revenue stood at $2.2 million in 2012, then dropped by 4.54% to $2.1 million in 2013, then crashed by 95.04% to $102000.0 in 2014, then plummeted by 35.29% to $66000.0 in 2015, then fell by 27.27% to $48000.0 in 2016.
  • Its Non-Current Deffered Revenue stands at $48000.0 for Q4 2016, versus $59000.0 for Q3 2016 and $56000.0 for Q2 2016.